Atara Biotherapeutics Inc (ATRA)
0.6911
-0.01
(-1.24%)
USD |
NASDAQ |
Apr 26, 16:00
0.6911
0.00 (0.00%)
After-Hours: 20:00
Atara Biotherapeutics Total Assets (Quarterly): 165.50M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 165.50M |
| September 30, 2023 | 188.79M |
| June 30, 2023 | 246.44M |
| March 31, 2023 | 302.08M |
| December 31, 2022 | 376.42M |
| September 30, 2022 | 368.32M |
| June 30, 2022 | 436.12M |
| March 31, 2022 | 397.28M |
| December 31, 2021 | 468.13M |
| September 30, 2021 | 449.92M |
| June 30, 2021 | 456.79M |
| March 31, 2021 | 529.64M |
| December 31, 2020 | 588.12M |
| September 30, 2020 | 405.53M |
| June 30, 2020 | 428.11M |
| March 31, 2020 | 299.55M |
| December 31, 2019 | 342.94M |
| September 30, 2019 | 364.78M |
| June 30, 2019 | 274.14M |
| March 31, 2019 | 324.73M |
| December 31, 2018 | 391.84M |
| Date | Value |
|---|---|
| September 30, 2018 | 442.94M |
| June 30, 2018 | 492.71M |
| March 31, 2018 | 473.11M |
| December 31, 2017 | 217.78M |
| September 30, 2017 | 229.69M |
| June 30, 2017 | 244.16M |
| March 31, 2017 | 241.74M |
| December 31, 2016 | 263.91M |
| September 30, 2016 | 284.42M |
| June 30, 2016 | 300.81M |
| March 31, 2016 | 312.98M |
| December 31, 2015 | 324.98M |
| September 30, 2015 | 340.38M |
| June 30, 2015 | 161.10M |
| March 31, 2015 | 169.82M |
| December 31, 2014 | 106.12M |
| September 30, 2014 | 54.12M |
| June 30, 2014 | 58.50M |
| March 31, 2014 | 62.87M |
| December 31, 2013 | 51.83M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
165.50M
Minimum
Dec 2023
588.12M
Maximum
Dec 2020
373.08M
Average
376.42M
Median
Dec 2022
Total Assets (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 9.034M |
| Palatin Technologies Inc | 13.55M |
| iBio Inc | 34.02M |
| Theriva Biologics Inc | 55.22M |
| Oragenics Inc | 4.966M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 264.74M |
| Shareholders Equity (Quarterly) | -99.23M |
| Current Ratio | 0.7162 |